OPA1 and cardiovascular disorder: Regulates OPA1 protein expression to modulate mitochondrial function, affecting the proliferation and migration of vascular endothelial cells. It also acts on the NF-κB signaling pathway, inhibiting the transmission of inflammatory signals to mitochondria, reducing oxidative stress, and stabilizing intracellular homeostasis to improve cardiovascular diseases and atherosclerosis.